LEP and polycystic ovary syndrome: Emerging therapeutic research positions resveratrol as a dual modulator capable of normalizing this leptin-APN axis imbalance, suggesting its lipid-modulating efficacy in PCOS arises through pleiotropic mechanisms involving adipokines pathways related to leptin and APN (80).